• Chest · Mar 2014

    Lung cancer in the province of ávila (Spain): incidence, basic epidemiology of 2012, and trends in the past two decades.

    • Jesus Hernandez-Hernandez, Mbelen Moreno de Vega-Herrero, Miguel Iglesias-Heras, Ruth García-García, Jangel Tapias Del Pozo, José Alonso-Muñoz, Elena Filipovich Vegas, José Celdrán Gil, Fernando Hernandez-Terciado, and Raquel Tur González.
    • Chest. 2014 Mar 1;145(3 Suppl):338A.

    Session TitleLung Cancer Posters ISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: In the last decades, major changes are in the habit of tobacco consumption. We analyze key epidemiological data for lung cancer (LC) diagnosed in 2012 in the province of Ávila (Spain) and compared with previous available for trends in the past 20 years.MethodsInclusion: prospective search of patients diagnosed with LC in Avila in 2012. We studied incidence rates, age, smoking and histology, comparing these data with those obtained with the same methodology in previous prospective studies since 1992, every five years. We lack the data age-adjusted rates of 1992.ResultsIn 2012: 81 LC (70 men-11 women); crude incidence rates and age-adjusted rates to world standard population, respectively: 47.3 and 18.16. By gender, respectively: men 80.99 and 31.23 per 100.000, women 12.97 and 5.68 per 100.000. Previous years, respectively crude and adjusted rates, in men: 1992: 60.42 and -, 1997: 71.82 and 36.89; 2002: 89.92 and 39.76; 2007: 84.81 and 32.28. In women: 1992: 1.73 and -, 1997: 10.38 and 5.93; 2002: 15.93 and 14.96 and in 2007: 9.55 and 4.75. Average age in 2012 was 72.1 years (± 10.3) and previous studies: 1992: 67.4, 1997: 68, 2002: 68.04 and 2007: 71.6 years. In 2012 had been smokers 65 patients (80.25%), 63 men (90%) and 2 women (18.2%). The percentage of smokers, overall, men and women respectively were: 1992: 97.2%, 100%, 0%, 1997: 88.9%, 98.4%, 11.1%, 2002: 87.3% , 98.6%, 23.1% and 2007: 92.3%, 97.2%, 33.33%. In 2012, diagnosed by cytology or histology 72 (88.9%): adenocarcinoma (37.5%), squamous (33.3%), small cell (13.9%), non-small cell undifferentiated (11.1%), large cell (2.8%) and carcinoid tumor (1.4%). In previous studies, adenocarcinomas, squamous, and small cell respectively: 1992: 13.2%, 59.4%, 24.3%, 2007: 25.4%, 47.6%, 20.6%, 2002: 17.1% 38.1% 30.2% 2007 11.3%, 50%, 17.7%.ConclusionsMales: a climb in the LC incidence rates between 1992 and 2002. After, remained high appreciating just a slight decrease. Women: lower rates, grew until 2002 but after are relatively stable. We can see a rise in the age at diagnosis and the percentage of adenocarcinomas and decrease of smokers and squamous and small cell histology.Clinical ImplicationsLC is still a major clinical problem in Avila (Spain)DisclosureThe following authors have nothing to disclose: Jesus Hernandez-Hernandez, MBelen Moreno de Vega-Herrero, Miguel Iglesias-Heras, Ruth García-García, JAngel Tapias del Pozo, José Alonso-Muñoz, Elena Filipovich Vegas, José Celdrán Gil, Fernando Hernandez-Terciado, Raquel Tur GonzálezNo Product/Research Disclosure Information.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.